Literature DB >> 20846674

Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin.

Isidre Ferrer1.   

Abstract

The term cognitive impairment of vascular origin is used to designate global cognitive deficits as well as focal neurological deficits such as aphasia, apraxia and agnosia of vascular/circulatory origin. It has been useful for identifying early clinical and neuroradiological alterations that might permit therapeutic strategies geared to curbing the progression of cerebrovascular disease. Multi-infarct encephalopathy, infarcts in strategic areas, lacunae and lacunar status, Binswanger's encephalopathy, hippocampal sclerosis, cortical granular atrophy and watershed infarcts are common lesions. Hypertension and vascular diseases such as arteriosclerosis, small blood vessel disease, inflammatory diseases of the blood vessels, Sneddon syndrome, cerebral amyloid angiopathies, cerebral autosomic dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and Maeda's syndrome are causative of cognitive impairment of vascular origin. Other less common causes are hereditary endotheliopathy with retinopathy, neuropathy and strokes (HERNS), cerebro-retinian vasculopathy (CRV), hereditary vascular retinopathy (HVR) (all three linked to 3p21.1-p21.3), hereditary infantile hemiparesis with arteriolar retinopathy and leukoencephalopathy (HIHRATL) (not linked to 3p21), fibromuscular dysplasia, and moya-moya disease. Lack of uniformity of clinical manifestations, the variety of vascular diseases and circulatory factors, the diverse, but often convergent, neuropathological substrates, and the common association with unrelated neurodegenerative diseases in the elderly, make it hard to assume a single clinical approach in the diagnosis and treatment of cognitive impairment of vascular origin. Rather, environmental and genetic risk factors, underlying vascular diseases, associated systemic, metabolic and neurodegenerative diseases and identification of extent and distribution of lesions with morphological and functional neuroimaging methods should be applied in every individual patient.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20846674     DOI: 10.1016/j.jns.2010.08.039

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

1.  Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease.

Authors:  Salo Haratz; Galit Weinstein; Noa Molshazki; Michal Schnaider Beeri; Ramit Ravona-Springer; Oleg Marzeliak; Uri Goldbourt; David Tanne
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  The Glymphatic System: A Beginner's Guide.

Authors:  Nadia Aalling Jessen; Anne Sofie Finmann Munk; Iben Lundgaard; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2015-05-07       Impact factor: 3.996

Review 3.  Vascular disease and dementias: paradigm shifts to drive research in new directions.

Authors:  Mitchel A Kling; John Q Trojanowski; David A Wolk; Virginia M Y Lee; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

Review 4.  PET imaging in ischemic cerebrovascular disease: current status and future directions.

Authors:  Wolf-Dieter Heiss
Journal:  Neurosci Bull       Date:  2014-08-19       Impact factor: 5.203

Review 5.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 6.  The potential role of perlecan domain V as novel therapy in vascular dementia.

Authors:  Aileen Marcelo; Gregory Bix
Journal:  Metab Brain Dis       Date:  2014-06-27       Impact factor: 3.584

7.  Acute watershed infarcts with global cerebral hypoperfusion in symptomatic CADASIL.

Authors:  Ajeet Gordhan; Brian K Hudson
Journal:  J Radiol Case Rep       Date:  2013-03-01

Review 8.  Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain.

Authors:  Dietmar Rudolf Thal; Lea Tenenholz Grinberg; Johannes Attems
Journal:  Exp Gerontol       Date:  2012-06-13       Impact factor: 4.032

Review 9.  Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.

Authors:  Daejin Lim; Jae-Ho Jeong; Juhyun Song
Journal:  CNS Neurosci Ther       Date:  2021-05-04       Impact factor: 5.243

Review 10.  Brain arteriolosclerosis.

Authors:  Brittney L Blevins; Harry V Vinters; Seth Love; Donna M Wilcock; Lea T Grinberg; Julie A Schneider; Rajesh N Kalaria; Yuriko Katsumata; Brian T Gold; Danny J J Wang; Samantha J Ma; Lincoln M P Shade; David W Fardo; Anika M S Hartz; Gregory A Jicha; Karin B Nelson; Shino D Magaki; Frederick A Schmitt; Merilee A Teylan; Eseosa T Ighodaro; Panhavuth Phe; Erin L Abner; Matthew D Cykowski; Linda J Van Eldik; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2020-10-24       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.